THE MBL77 DIARIES

Deep, specific next-technology sequencing has discovered that subclonal mutations (i.e., Individuals existing in only a fraction of tumor cells) may be detected for all driver genes and they are connected with swift disorder progression and very poor result.11–thirteen This is particularly applicable for TP53Not all patients with CLL need therapy